Product logins

Find logins to all Clarivate products below.


Aortic Repair Devices | Market Insights | Japan | 2022

Despite the negative—albeit relatively limited—impact of the ongoing COVID-19 pandemic, the Japanese aortic repair device market will grow at a modest rate, which in turn is attributed to shift towards premium-priced endovascular procedures, large and expanding patient pool, and launch of new aortic repair devices in Japan during the forecast period. However, the growth will be limited to some extent by unavailability of certain aortic stent graft brands and pricing pressure due to changes in reimbursement.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for aortic repair devices in Japan from 2019 through 2031.

Related Medtech Insights Reports

Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2034, driven by rising demand for MIS procedures among the country’s rapidly aging population. Additionally, the adoption of…
Report
Urological Devices – Market Insights – Japan
The Japanese urological device market will continue to expand through 2034, driven by the rising prevalence of risk factors for urological disorders, such as the growing burden of metabolic…
Report
Aortic Repair Devices – Market Insights – Asia Pacific
The Asia Pacific aortic repair device market is projected to experience robust growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Japan
The Japanese EP mapping and ablation device market will experience moderate growth through 2034, supported by rising cardiac arrhythmia prevalence, broader treatment accessibility, and ongoing…